Noncompliance with arthritis drugs: magnitude, correlates, and clinical implications

R. A. Deyo, T. S. Inui, B. Sullivan

Research output: Contribution to journalArticlepeer-review

65 Scopus citations


Objective information on arthritis drug compliance in usual care settings is sparse. Of 'causes' of poor compliance, regimen complexity has received special attention. We used a previously validated pharmacy-based compliance measure to study compliance in an arthritis clinic. Across drugs, mean compliance was low (64%). Wide variations were seen among drugs, ranging from 55% mean compliance (indomethacin) to over 80% (prednisone, penicillamine). Major variations by diagnosis were also found, with rheumatoid arthritis patients more compliant than others. Regimen complexity was a relatively weak correlate of compliance, and the overall level of arthritis drug compliance was similar to that reported for antihypertensive drugs.

Original languageEnglish (US)
Pages (from-to)931-936
Number of pages6
JournalJournal of Rheumatology
Issue number6
StatePublished - Dec 1 1981

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Noncompliance with arthritis drugs: magnitude, correlates, and clinical implications'. Together they form a unique fingerprint.

Cite this